BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
BioLineRx Ltd. Reports Successful Top-Line Safety And Efficacy Results For Novel Stem Cell Mobilization Treatment 3/25/2015 10:59:02 AM
BioLineRx Ltd. Reports Year End 2014 Financial Results 3/23/2015 9:31:50 AM
BioLineRx Ltd. To Report Fourth Quarter And Year End 2014 Results On March 23, 2015 3/17/2015 9:59:12 AM
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015 10:46:16 AM
BioLineRx Ltd.’s Treatment for Type 1 Diabetes Effective In Preclinical Trials 3/11/2015 9:26:15 AM
BioLineRx Ltd. To Present At The Annual Roth Conference In California 3/6/2015 10:07:44 AM
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015 8:28:07 AM
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015 6:43:16 AM
BioLineRx Ltd. Announces Regulatory Submission For Phase 2b Trial For Novel AML Consolidation Treatment 3/2/2015 10:24:32 AM
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG (NVS) Partnership Terms 2/10/2015 3:48:25 PM
12345678910...